Marta Jimenez
Impact in
-
- Brain Metastases and Treatment
- Lung Cancer Treatments and Mutations
- Renal cell carcinoma treatment
- Sarcoma Diagnosis and Treatment
- Oncology top 5%
- Lung Cancer Research Studies
- HER2/EGFR in Cancer Research
Papers in
-
- Advanced Breast Cancer Therapies 9
- Sarcoma Diagnosis and Treatment 8
- Lung Cancer Treatments and Mutations 6
- Oncology 26
- HER2/EGFR in Cancer Research 8
- Cancer Immunotherapy and Biomarkers 5
- PARP inhibition in cancer therapy 5
- Cancer Treatment and Pharmacology 4
- Co-authors
- Mario Campone (17 shared papers)Véronique Dièras (15 shared papers)Thomas Bachelot (16 shared papers)Florence Dalenc (12 shared papers)Anthony Gonçalvès (11 shared papers)Jean-Marc Ferrero (3 shared papers)C. Labbé-Devilliers (1 shared paper)Julien Dômont (1 shared paper)
- Journals
- Journal of Clinical Oncology (20 papers)Annals of Oncology (13 papers)Cancer Research (3 papers)The Lancet Oncology (2 papers)European Journal of Cancer (2 papers)
- Partner nations
- FranceItalyUnited States
In The Last Decade
Marta Jimenez
48 papers receiving 1.4k citations
Marta Jimenez's Hit Papers
Peers
Comparison fields: 5 of 67
- Pulmonary and Respiratory Medicine 870
- Oncology 717
- Cancer Research 340
- Genetics 135
- Molecular Biology 297
Countries citing papers authored by Marta Jimenez
This map shows the geographic impact of Marta Jimenez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marta Jimenez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marta Jimenez more than expected).
Fields of papers citing papers by Marta Jimenez
This network shows the impact of papers produced by Marta Jimenez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marta Jimenez. The network helps show where Marta Jimenez may publish in the future.
Co-authors
The 25 scholars most cited alongside Marta Jimenez, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 51 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Lapatinib plus capecitabine in patients with previously untreated brain metastases from HER2-positive metastatic breast cancer (LANDSCAPE): a single-group phase 2 study Hit paper breakdown → | 2012 | 561 |
| 2 | 2014 | 259 | |
| 3 | 2017 | 142 | |
| 4 | 2015 | 125 | |
| 5 | 2015 | 40 | |
| 6 | 2021 | 34 | |
| 7 | 2019 | 23 | |
| 8 | 2020 | 21 | |
| 9 | 2017 | 19 | |
| 10 | 2013 | 17 | |
| 11 | 2014 | 14 | |
| 12 | 2017 | 13 | |
| 13 | 2022 | 13 | |
| 14 | 2008 | 13 | |
| 15 | 2019 | 12 | |
| 16 | 2009 | 12 | |
| 17 | 2016 | 12 | |
| 18 | 2009 | 11 | |
| 19 | 2020 | 11 | |
| 20 | 2023 | 10 |
About Marta Jimenez
Marta Jimenez is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Cancer Research, Molecular Biology and Surgery, having authored 51 papers that have together received 1.5k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (12 papers), Advanced Breast Cancer Therapies (9 papers), Sarcoma Diagnosis and Treatment (8 papers), HER2/EGFR in Cancer Research (8 papers), Lung Cancer Treatments and Mutations (6 papers), Cancer Immunotherapy and Biomarkers (5 papers), PARP inhibition in cancer therapy (5 papers) and Cancer Treatment and Pharmacology (4 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (870 citations), Oncology (717 citations), Cancer Research (340 citations), Genetics (135 citations) and Molecular Biology (297 citations). Marta Jimenez has collaborated with scholars based in France, Italy and United States. Frequent co-authors include Mario Campone, Véronique Dièras, Thomas Bachelot, Florence Dalenc, Anthony Gonçalvès, Jean-Marc Ferrero, C. Labbé-Devilliers, Julien Dômont, Gilles Romieu and Jean‐Yves Pierga. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Cancer Research, The Lancet Oncology and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.